Autolus Therapeutics (AUTL) Accumulated Depreciation & Amortization: 2021-2025
Historic Accumulated Depreciation & Amortization for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to $2.1 million.
- Autolus Therapeutics' Accumulated Depreciation & Amortization rose 7.28% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 8.83%. This contributed to the annual value of $7.6 million for FY2024, which is 15.06% up from last year.
- As of Q3 2025, Autolus Therapeutics' Accumulated Depreciation & Amortization stood at $2.1 million, which was down 0.19% from $2.1 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization registered a high of $40.3 million during Q3 2021, and its lowest value of -$3.8 million during Q3 2022.
- In the last 3 years, Autolus Therapeutics' Accumulated Depreciation & Amortization had a median value of $1.9 million in 2023 and averaged $1.8 million.
- Over the last 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization had its largest YoY gain of 199.82% in 2022, and its largest YoY loss of 109.47% in 2022.
- Over the past 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $550,000 in 2021, then skyrocketed by 199.82% to $1.6 million in 2022, then rose by 7.64% to $1.8 million in 2023, then rose by 7.89% to $1.9 million in 2024, then increased by 7.28% to $2.1 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $2.1 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.0 million for Q1 2025.